Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Formestane: effective therapy in postmenopausal women with advanced breast cancer
E Bajetta, N Zilembo, R Buzzoni, et al.
The International Journal of Biological Markers
|
July 29, 1998
Chromogranin A measurement in neuroendocrine tumors
L Ferrari, E Seregni, A Martinetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2003
Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer
E Bajetta, L Celio, R Buzzoni, et al.
Anticancer Research
|
June 9, 2001
p53 evaluation in gastric mucosa of patients with chronic Helicobacter pylori infection
C Marinone, A Martinetti, M Mestriner, et al.
Cancer
|
August 27, 1999
Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors
E Bajetta, L Ferrari, A Martinetti, et al.
Oncology
|
May 1, 1994
Goserelin in premenopausal advanced breast cancer: clinical and endocrine evaluation of responsive patients
E Bajetta, N Zilembo, R Buzzoni, et al.
Oncology Reports
|
May 9, 1998
S100 protein serum levels in cutaneous malignant melanoma
E Seregni, S Massaron, A Martinetti, et al.
The International Journal of Biological Markers
|
January 11, 2003
Serum levels of tartrate-resistant acid phosphatase-5b in breast cancer patients treated with pamidronate
A Martinetti, E Seregni, C Ripamonti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2002
Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism
E Bajetta, A Martinetti, N Zilembo, et al.
Breast Cancer Research and Treatment
|
January 1, 1994
Effect of two-4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer
L Ferrari, N Zilembo, E Bajetta, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Formestane: effective therapy in postmenopausal women with advanced breast cancer
E Bajetta, N Zilembo, R Buzzoni, et al.
The International Journal of Biological Markers
|
July 29, 1998
Chromogranin A measurement in neuroendocrine tumors
L Ferrari, E Seregni, A Martinetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2003
Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer
E Bajetta, L Celio, R Buzzoni, et al.
Anticancer Research
|
June 9, 2001
p53 evaluation in gastric mucosa of patients with chronic Helicobacter pylori infection
C Marinone, A Martinetti, M Mestriner, et al.
Cancer
|
August 27, 1999
Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors
E Bajetta, L Ferrari, A Martinetti, et al.
Oncology
|
May 1, 1994
Goserelin in premenopausal advanced breast cancer: clinical and endocrine evaluation of responsive patients
E Bajetta, N Zilembo, R Buzzoni, et al.
Oncology Reports
|
May 9, 1998
S100 protein serum levels in cutaneous malignant melanoma
E Seregni, S Massaron, A Martinetti, et al.
The International Journal of Biological Markers
|
January 11, 2003
Serum levels of tartrate-resistant acid phosphatase-5b in breast cancer patients treated with pamidronate
A Martinetti, E Seregni, C Ripamonti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2002
Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism
E Bajetta, A Martinetti, N Zilembo, et al.
Breast Cancer Research and Treatment
|
January 1, 1994
Effect of two-4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer
L Ferrari, N Zilembo, E Bajetta, et al.
Page
of 6